Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Larney

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
BMC Infectious Diseases|May 11, 2018
Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012Maryam Alavi, Jason Grebely, Behzad Hajarizadeh, et al.
Addiction (Abingdon, England)|June 7, 2017
New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs-announcing an Addiction seriesMatthew Hickman, Jason Grebely, Julie Bruneau, et al.
Drug and Alcohol Dependence|October 30, 2020
Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: Findings from the OATS retrospective cohort studyNicola R Jones, Matthew Hickman, Sarah Larney, et al.
Drug and Alcohol Dependence|February 23, 2020
Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic reviewSamantha Colledge, Janni Leung, Jason Grebely, et al.
Canadian Journal of Pain = Revue Canadienne De La Douleur|February 11, 2026
Substance use frequency and associations with chronic pain among a cohort of people who inject drugs in Montreal, CanadaSasha Udhesister, Sarah Larney, M Gabrielle Pagé, et al.
Drug and Alcohol Dependence|May 23, 2022
The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage studySamantha Colledge-Frisby, Nicola Jones, Sarah Larney, et al.
The International Journal on Drug Policy|January 22, 2025
Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022Camille Zolopa, Thomas D Brothers, Pascale Leclerc, et al.
Pain Medicine (Malden, Mass.)|April 13, 2017
Prescription Opioid Access Patterns and Factors Associated with Increasing Number of Prescribers, Pharmacies, and Dispensings: An Observational Study Using Pharmaceutical ClaimsBianca Blanch, Louisa Degenhardt, Nicholas A Buckley, et al.
The International Journal on Drug Policy|October 29, 2022
Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series studyCamille Zolopa, Thomas D Brothers, Pascale Leclerc, et al.
Pharmacoepidemiology and Drug Safety|October 20, 2017
To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Natasa Gisev, Sallie-Anne Pearson, Emily A Karanges, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
BMC Infectious Diseases|May 11, 2018
Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012Maryam Alavi, Jason Grebely, Behzad Hajarizadeh, et al.
Addiction (Abingdon, England)|June 7, 2017
New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs-announcing an Addiction seriesMatthew Hickman, Jason Grebely, Julie Bruneau, et al.
Drug and Alcohol Dependence|October 30, 2020
Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: Findings from the OATS retrospective cohort studyNicola R Jones, Matthew Hickman, Sarah Larney, et al.
Drug and Alcohol Dependence|February 23, 2020
Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic reviewSamantha Colledge, Janni Leung, Jason Grebely, et al.
Canadian Journal of Pain = Revue Canadienne De La Douleur|February 11, 2026
Substance use frequency and associations with chronic pain among a cohort of people who inject drugs in Montreal, CanadaSasha Udhesister, Sarah Larney, M Gabrielle Pagé, et al.
Drug and Alcohol Dependence|May 23, 2022
The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage studySamantha Colledge-Frisby, Nicola Jones, Sarah Larney, et al.
The International Journal on Drug Policy|January 22, 2025
Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022Camille Zolopa, Thomas D Brothers, Pascale Leclerc, et al.
Pain Medicine (Malden, Mass.)|April 13, 2017
Prescription Opioid Access Patterns and Factors Associated with Increasing Number of Prescribers, Pharmacies, and Dispensings: An Observational Study Using Pharmaceutical ClaimsBianca Blanch, Louisa Degenhardt, Nicholas A Buckley, et al.
The International Journal on Drug Policy|October 29, 2022
Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series studyCamille Zolopa, Thomas D Brothers, Pascale Leclerc, et al.
Pharmacoepidemiology and Drug Safety|October 20, 2017
To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Natasa Gisev, Sallie-Anne Pearson, Emily A Karanges, et al.
Pageof 19